|
Nolvadex is an anticancer drug which is reportedly effective in treating breast cancer, particularly the kind that is induced by estrogen. Its other therapeutic uses include reduction of the risk of invasive breast cancer following surgery and radiation therapy for ductal carcinoma in situ. Nolvadex is also used as preventive drug. It is prescribed in women who are at high risk of developing breast cancer (genetic disposition).
Breast Cancer Treatment
For patients with breast cancer, the recommended daily dose is 20-40 mg. Dosages greater than 20 mg per day should be given in divided doses (morning and evening).
Ductal Carcinoma in Situ (DCIS)
The recommended dose is Nolvadex 20 mg daily for 5 years.
Reduction in Breast Cancer Incidence in High Risk Women
The recommended dose is Nolvadex 20 mg daily for 5 years. There are no data to support the use of Nolvadex other than for 5 years.
|
